Common Contracts
2 similar Research and Commercialization Agreement contracts by Fibrogen Inc
EX-10.21 39 d720189dex1021.htm EX-10.21 CONFIDENTIAL RESEARCH AND COMMERCIALIZATION AGREEMENTResearch and Commercialization Agreement • May 5th, 2020 • California
THIS RESEARCH AND COMMERCIALIZATION AGREEMENT (the “Agreement”), effective as of July 9, 1998, is entered by and between GenPharm International, Inc., a wholly owned subsidiary of Medarex, Inc., and Medarex, Inc., a New Jersey corporation, with a principal place of business at 1545 Route 22 East, Annandale, New Jersey 08801 (together “Medarex”), and FibroGen, Inc. and its wholly-owned subsidiary, FibroPharma, Inc., with a principal place of business at 225 Gateway Boulevard, South San Francisco, California 94080 (together “FibroGen”).
RESEARCH AND COMMERCIALIZATION AGREEMENTResearch and Commercialization Agreement • August 8th, 2014 • Fibrogen Inc • Pharmaceutical preparations • California
